Gradual loss of CD28 on T cells has been shown to be the result of aging as well as prolonged antigenic stimulation during HIV-1 infection; effective ART administration has however been shown to shift this pathological parameter into a state where the majority of CD8 + T cells express CD2830. The gene discussed is CD28; the disease is HIV-1 infection.